These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 7536445

  • 1. Bone metabolism in premenopausal women with nontoxic goiter and reduced serum thyrotropin levels.
    Faber J, Overgaard K, Jarløv AE, Christiansen C.
    Thyroidology; 1994 Apr; 6(1):27-32. PubMed ID: 7536445
    [Abstract] [Full Text] [Related]

  • 2. Thyroid hormone treatment aiming at reduced, but not suppressed, serum thyroid-stimulating hormone levels in nontoxic goitre: effects on bone metabolism amongst premenopausal women.
    Knudsen N, Faber J, Sierbaek-Nielsen A, Vadstrup S, Sørensen HA, Hegedüs L.
    J Intern Med; 1998 Feb; 243(2):149-54. PubMed ID: 9566644
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre.
    De Rosa G, Testa A, Maussier ML, Callà C, Astazi P, Albanese C.
    Horm Metab Res; 1995 Nov; 27(11):503-7. PubMed ID: 8770627
    [Abstract] [Full Text] [Related]

  • 5. Bone Gla protein and sex hormone-binding globulin in nontoxic goiter: parameters for metabolic status at the tissue level.
    Faber J, Perrild H, Johansen JS.
    J Clin Endocrinol Metab; 1990 Jan; 70(1):49-55. PubMed ID: 2294139
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
    Kumeda Y, Inaba M, Tahara H, Kurioka Y, Ishikawa T, Morii H, Nishizawa Y.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lack of influence of simple premenopausal hysterectomy on bone mass and bone metabolism.
    Ravn P, Lind C, Nilas L.
    Am J Obstet Gynecol; 1995 Mar; 172(3):891-5. PubMed ID: 7892881
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women.
    Marcocci C, Golia F, Bruno-Bossio G, Vignali E, Pinchera A.
    J Clin Endocrinol Metab; 1994 Apr; 78(4):818-23. PubMed ID: 8157704
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis.
    Faber J, Galløe AM.
    Eur J Endocrinol; 1994 Apr; 130(4):350-6. PubMed ID: 8162163
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.